SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-018426
Filing Date
2023-05-22
Accepted
2023-05-19 19:26:29
Documents
48
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 642436
2 ex31-1.htm EX-31.1 17850
3 ex31-2.htm EX-31.2 18328
4 ex32-1.htm EX-32.1 7224
5 ex32-2.htm EX-32.2 7143
  Complete submission text file 0001493152-23-018426.txt   3588181

Data Files

Seq Description Document Type Size
6 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT hils-20230331.xsd EX-101.SCH 25623
7 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT hils-20230331_cal.xml EX-101.CAL 31190
8 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT hils-20230331_def.xml EX-101.DEF 132884
9 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT hils-20230331_lab.xml EX-101.LAB 258399
10 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT hils-20230331_pre.xml EX-101.PRE 210735
42 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 396235
Mailing Address 245 MAIN STREET SUITE 204 CHESTER NJ 07930
Business Address 1200 ROUTE 22 EAST BRIDGEWATER NJ 08807 302-743-2995
Hillstream BioPharma Inc. (Filer) CIK: 0001861657 (see all company filings)

IRS No.: 842642541 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41210 | Film No.: 23942077
SIC: 2834 Pharmaceutical Preparations